The European Medicines Agency has released documents that it had previously refused to disclose, following a recommendation of the European Ombudsman.
The London-based agency has agreed to release reports on the adverse effects of a medicine called Septrin, after a Greek law firm complained to the Ombudsman that access to the documents had been denied.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.